Clinical trial
A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle…
NCT00150267 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00150267 |
|---|---|
| Title | A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension |
| Official title | A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Glaucoma, Open-Angle, Ocular Hypertension |
| Intervention type | Drug |
| Interventions | Xalacom |
| Enrollment | 976 |
| Start date | Feb 1, 2002 |
| First posted | Sep 8, 2005 |
| Last update posted | Nov 5, 2008 |
| Countries | Australia, Belgium, Denmark, France, Germany, Greece, Ireland, Italy, Netherlands, Spain, Sweden, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: